Previous close | 9.96 |
Open | 9.99 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 9.99 - 10.09 |
52-week range | 9.99 - 10.09 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 0.85 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Earnings preview of key companies reporting next week and what to look out for.
** Novo Nordisk notched a win in its race to boost output of its popular obesity drug Wegovy, with its parent company announcing it was buying Catalent, a key manufacturing subcontractor of the product, for $16.5 billion. ** Brazilian fashion companies Arezzo & Co and Grupo Soma said they had agreed to a merger to form an entity with yearly revenues of 12 billion reais ($2.42 billion), which will be 54% controlled by Arezzo. ** Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said.